Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005327947 | SCV006005020 | uncertain significance | not specified | 2025-01-27 | criteria provided, single submitter | clinical testing | The c.2838G>T (p.E946D) alteration is located in exon 21 (coding exon 21) of the FLT1 gene. This alteration results from a G to T substitution at nucleotide position 2838, causing the glutamic acid (E) at amino acid position 946 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |